{'fraction_non_alphanumeric': 0.023376623376623377, 'fraction_numerical': 0.025974025974025976, 'mean_word_length': 4.976744186046512, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Surgical experience with juvenile nasopharyngeal angiofibroma.

A retrospective analysis was made of 24 cases of nasopharyngeal angiofibroma treated by the ENT Department of the Hospital de Clínicas de Porto Alegre between 1975 and 1989. All the patients were male with an average age of 16. All were treated by surgery alone, with an average peri-operative blood loss of 1,784 ml; pre-operative embolization made no significant difference to the blood loss. No other operative complications were encountered. Five patients (21%) had a recurrence, one of which was intracranial and required further surgery to effect a cure. The average length of follow-up was 19 months. We believe that surgical excision must be the treatment of choice for nasopharyngeal angiofibroma.